SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes
about
Insights into the antimicrobial properties of hepcidins: advantages and drawbacks as potential therapeutic agentsSMAP-29 has two LPS-binding sites and a central hingeAntimicrobial Activity of Cationic Antimicrobial Peptides against Gram-Positives: Current Progress Made in Understanding the Mode of Action and the Response of BacteriaCathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulationCathelicidins in the Tasmanian devil (Sarcophilus harrisii)Human antimicrobial peptides and proteinsGene cloning, expression and characterization of avian cathelicidin orthologs, Cc-CATHs, from Coturnix coturnix.Evaluation of amoebicidal potential of Paneth cell cryptdin-2 against Entamoeba histolytica.Antimicrobial activity of human EPPIN, an androgen-regulated, sperm-bound protein with a whey acidic protein motif.Engineered bacteriophage lysins as novel anti-infectivespH-dependent disruption of Escherichia coli ATCC 25922 and model membranes by the human antimicrobial peptides hepcidin 20 and 25.Ion channel formation and membrane-linked pathologies of misfolded hydrophobic proteins: the role of dangerous unchaperoned molecules.Bacterial killing mechanism of sheep myeloid antimicrobial peptide-18 (SMAP-18) and its Trp-substituted analog with improved cell selectivity and reduced mammalian cell toxicity.Antimicrobial peptide killing of African trypanosomes.Induction of group A Streptococcus virulence by a human antimicrobial peptide.In vitro activity of a partially purified and characterized bark extract of Castanea sativa Mill. (ENC®) against Chlamydia spp.A cumulative experience examining the effect of natural and synthetic antimicrobial peptides vs. Chlamydia trachomatis.Descriptors for antimicrobial peptides.In silico analysis of antifungal peptides.Biodegradable Antimicrobial Polycarbonates with In Vivo Efficacy against Multidrug-Resistant MRSA Systemic Infection.Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock.Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences.Antibacterial and antifungal properties of alpha-helical, cationic peptides in the venom of scorpions from southern Africa.Purification and characterization of a lipopeptide produced by Bacillus thuringiensis CMB26.Purification and characterization of a novel antimicrobial peptide from sheep reproductive tract.SMAP29 congeners demonstrate activity against oral bacteria and reduced toxicity against oral keratinocytes.Natural Antimicrobial Peptides as Inspiration for Design of a New Generation Antifungal Compounds.The stereochemical effect of SMAP-29 and SMAP-18 on bacterial selectivity, membrane interaction and anti-inflammatory activity.Osmoprotective polymer additives attenuate the membrane pore-forming activity of antimicrobial peptoids.Solution structure of a cathelicidin-derived antimicrobial peptide, CRAMP as determined by NMR spectroscopy.Structural aspects and biological properties of the cathelicidin PMAP-36
P2860
Q26991996-EB2C3892-4FEB-4B13-8A4C-0F5790E81620Q27637934-EA36F7BF-EC9A-427D-96F5-D7103F7EDE96Q28072687-4A03D62A-2022-4DEB-8AC0-C0045CCA8DA9Q28534617-FA60DA14-FE36-4FBE-B30E-E0DA86F2E3C5Q29042110-758690DE-7B4C-424B-A9C9-9674A80AA4BEQ33673156-8C73CF07-7217-480F-B627-C9BF77978994Q33837370-06B2A34D-12A4-4C21-8249-DA61C847F952Q34113775-E192113F-8F64-45CD-B43B-13DA1A964AA0Q34330422-99470C10-53B1-473A-A46D-D99BA243ED66Q34349552-ED9F8B7F-3DC0-464E-BB64-1324368AF28DQ34669079-F7DFD58E-2D08-46C9-B8E3-50EBD82B8A2EQ34775436-F8653046-4C6E-4EED-B1DD-741AD5EBA039Q35039695-432F7D1A-E288-4E2F-AFC4-B409377E5789Q35112654-8B948865-93EF-437A-AF9C-227DEA8D8FECQ36954965-EA6AD5EB-5B0F-4CCA-9FA5-409F7CA578C7Q37834775-66F83F08-AC17-4555-8615-4BB0D7D46503Q37866767-70806570-2DD8-465F-9E69-FFE8D5E2E1DDQ38014581-597E2378-C6DE-4A6E-8E8D-9CF41EAE78B4Q38089155-BBD7D89D-FE1C-45F9-9E27-F9A51D2C2D06Q40583200-52AECAB1-180D-4D25-B936-DA72FD64D3B1Q43506522-23C99777-39B7-4CF5-86C6-E2F77DF22679Q44020584-12F704F3-4207-4CB1-9D6A-DD08955063F9Q44158394-F7E979D1-59AA-4680-A275-33F9F554CFFEQ45103028-807BFE11-B1B1-43CB-8863-981C9AA3C657Q46034354-B0E7A433-F733-440E-88D6-24D743D4550EQ46750707-061E17E1-E8D5-44A1-B770-993B0895E824Q48163141-9B614578-4253-499C-ADA1-875E586A40ADQ50889058-09A6E0EC-D301-48B6-93BC-4E04A5D547F6Q52655049-8D2C768B-8254-4527-99AD-E4EF65EC2A12Q53668672-F793F157-149A-4104-AD82-7EE33E13C49DQ57275274-39189926-DDEF-475A-A54A-976A4EA60089
P2860
SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes
description
im Dezember 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 December 1999
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 1999
@uk
name
SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes
@en
SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes
@nl
type
label
SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes
@en
SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes
@nl
prefLabel
SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes
@en
SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes
@nl
P2093
P2860
P921
P1433
P1476
SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes
@en
P2093
P2860
P356
10.1016/S0014-5793(99)01600-2
P407
P577
1999-12-01T00:00:00Z